peptide elongation factor 2 has been researched along with Cancer of Ovary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Gu, H; He, A; Liu, R; Shi, N; Su, M; Wang, D; Wang, Q | 1 |
| FitzGerald, DJ; Pastan, I; Willingham, MC | 1 |
1 review(s) available for peptide elongation factor 2 and Cancer of Ovary
| Article | Year |
|---|---|
Pseudomonas exotoxin--immunotoxins.
Topics: ADP Ribose Transferases; Animals; Antibodies, Monoclonal; Antibodies, Neoplasm; Bacterial Toxins; Cross-Linking Reagents; Drug Screening Assays, Antitumor; Epidermal Growth Factor; Exotoxins; Female; Genes, Bacterial; Humans; Immunotoxins; Mice; Mice, Nude; Ovarian Neoplasms; Peptide Elongation Factor 2; Peptide Elongation Factors; Protein Engineering; Pseudomonas aeruginosa; Pseudomonas aeruginosa Exotoxin A; Ricin; Transferrin; Virulence Factors | 1988 |
1 other study(ies) available for peptide elongation factor 2 and Cancer of Ovary
| Article | Year |
|---|---|
Eukaryotic elongation factors 2 promotes tumor cell proliferation and correlates with poor prognosis in ovarian cancer.
Topics: Adult; Aged; Aged, 80 and over; Cell Line, Tumor; Cell Proliferation; Female; Humans; Middle Aged; Neoplasm Proteins; Neoplasm Staging; Ovarian Neoplasms; Peptide Elongation Factor 2; Prognosis; Signal Transduction | 2018 |